Welcome Guest to Happi

Subscribe Free: Magazine | eNewsletter

current issue August 2015
 •  Split End Science  •  The Latest Active at Silab  •  Stepan Named EPA Safer Choice Partner of the Year  •  City of Hope Honors Pravana Founder & CEO Steve Goddard  •  Castanea Acquires Minority Stake in First Aid Beauty
Print

Fuji Chemical Granted Inflammation Patent



Published September 8, 2006
Related Searches: ink patent industry eye
Post a comment
Patent No. US 7,078,040 B2: Fuji Chemical Industry Co., Ltd., Mount Laurel, NJ has been granted a patent for inhibiting the expression of inflammatory cytokines and chemokines by the administration of astaxanthin. Fuji’s pending patents for astaxanthin include the areas of eye fatigue, wrinkle reduction, weight loss, diabetic nephropathy and dyspepsia.



blog comments powered by Disqus